Vanguard Reports 0% Stake in Hologic Due to Internal Realignment
HOLOGIC INC
Subscribe to track HOLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vanguard Reports 0% Stake in Hologic Due to Internal Realignment
Company: Hologic Inc (Hologic Inc) Form: SCHEDULE 13G/A | Filed: 2026/03/27 Significance: Low (Administrative)
Investor: The Vanguard Group Type: Institutional Investor
Filing Details: • Previous Stake: >5% (Implied by Amendment) • Current Stake: 0 shares (0.0%) • Reason: Internal corporate realignment
Key Insight: The Vanguard Group reports 0 beneficial ownership due to an internal realignment where subsidiaries now report separately. This does not necessarily indicate a liquidation of the underlying position by Vanguard funds, but a change in the reporting entity structure.
Market Context: Hologic has a market cap of $16.83B. This filing is technical in nature regarding beneficial ownership attribution.
Comprehensive Analysis
SEC Filing Analysis: Hologic Inc
Executive Summary
- Trading Significance: Low (Administrative)
- Key Takeaway: The Vanguard Group reports 0% ownership following an internal corporate realignment; subsidiaries will report separately.
- Market Impact: Neutral - This is a regulatory reporting change, not a signal of market disposition.
Company Information
| Field | Value |
|---|---|
| Company | HOLOGIC INC |
| CIK | 0000859737 |
| Industry | X-RAY APPARATUS & TUBES |
| Market Cap | $16.83 Billion |
Investor Information
| Field | Value |
|---|---|
| Name | The Vanguard Group |
| CIK | 0000102909 |
| Type | Institutional Investor |
| Location | Malvern, PA |
Transaction Details
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13G/A |
| Event Date | 2026/03/13 |
| Shares Owned After | 0 |
| Percent of Class | 0% |
| Ownership Type | N/A |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Post-Transaction Ownership | 0 shares (0.00% of outstanding) |
| Materiality Assessment | Low (Technical/Administrative) |
Impact Evaluation
- Market Cap Context: With a market cap of $16.83B, Hologic is a large-cap entity. Institutional shifts are usually significant, but this specific filing is administrative.
- Ownership Concentration: The filing indicates The Vanguard Group (parent) no longer holds reportable beneficial ownership. However, the footnotes clarify that subsidiaries now report separately, meaning the aggregate economic interest of Vanguard funds may remain unchanged.
- Transaction Significance: While the reduction to 0% appears drastic, the explanatory note cites SEC Release No. 34-39538 regarding disaggregated reporting, neutralizing the bearish signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing explicitly states the change is due to "internal realignment" and that subsidiaries pursuing the same investment strategies will report separately. This is not a sell-off.
Volume & Sentiment
- Expected Volume Impact: Negligible.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Special Circumstances: The filing contains a specific footnote: "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately... The Vanguard Group, Inc. no longer has... beneficial ownership over securities beneficially owned by such subsidiaries."
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.